Healthcare industry

Dossier - 28/08/2018

With molecular diagnostics to biomarker-based personalised therapy

Diagnosing suitable biomarkers is a prerequisite for tailoring personalised therapies to patient heterogeneity. Genetic tests and genome sequencing play a key role in these diagnoses. Up until now, personalised therapy has achieved the greatest success in the field of oncology. However, personalised treatments are also gaining in importance for treating other diseases.

Founded in 2000, the biopharmaceutical company CureVac is technology leader in the development of drugs that are based on the molecule Messenger RNA (mRNA).

trenzyme GmbH is a privately owned German Contract Research Organization (CRO) offering a wide range of highly customized services in cell line development and recombinant protein production.

Roche was founded in Switzerland (Basel) in 1896. Already in the following year, the German subsidiary in Grenzach was established. Roche is active in over 100 countries and employs more than 94,000 people worldwide.

Hain Lifescience GmbH is a manufacturer and distributor of molecular genetic test systems and instruments for diagnostic laboratories. The medium-sized company can look back on more than 30 years of experience in medical diagnostics. At the headquarters in Nehren over 100 employees are working.

Since 1983, PROGEN has been an established manufacturer and supplier of premium antibodies, in vitro diagnostics, and reagents for the global life science research community. PROGEN is DIN EN ISO 13485 certified and since 2012 a 100% subsidiary of R-Biopharm AG.

Based on our core competences in computational and synthetic biology ATG is the valuable partner for integrative biotech project plannings with a high impact on the development of new markets in a bio-based economy in terms of advanced bio-pharmaceutical, medical, veterinary and nutritional supply.

BioCat GmbH, located in the Heidelberg Technology Park, was founded in 2000 to market innovative products and services for life science research.BioCat offers a wide range of high-quality research reagents as well as cutting-edge technologies in the fields of genomics, proteomics, and cell biology.